Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Chen-Han Chueh

7PUBLICATIONS

18CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Economic models and forecastingDisease surveillanceGene and molecular therapyPredictive and prognostic markers

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (7)

Sort by Publication Date:

|Feb 11, 2026

Battle against time for innovative cancer treatment: an updated cost-effectiveness analysis of pemigatinib in intrahepatic cholangiocarcinoma.

I-Ting Wang, Hsiao-Lin Chen, Wei-Ming Huang

|Jan 15, 2026

Cost-effectiveness of lenvatinib plus pembrolizumab as the second-line treatment for advanced endometrial carcinoma.

Szu-Ting Chiang, Chen-Han Chueh, Yu-Wen Wen

|Oct 27, 2025

Impact of extended insurance coverage on survival outcomes among patients with metastatic colorectal cancer in Taiwan.

Wei-Ming Huang, Chen-Han Chueh, Chien-Yu Tseng

|Oct 16, 2025

The Cost-Effectiveness of Sugemalimab Plus CAPOX in Treating Advanced Gastric Cancer: Analysis from the GEMSTONE-303 Trial.

Chen-Han Chueh, Wei-Ming Huang, Ming-Yu Hong

|Jun 24, 2024

The 2017 Women's Health Initiative study and use of hormone therapy: an emulated repeated cross-sectional study.

Chen-Han Chueh, Pei-Kuan Ho, Wai-Hou Li

|Sep 11, 2023

Cost-effectiveness of pemigatinib as a second-line treatment for advanced intrahepatic cholangiocarcinoma with fibroblast growth factor receptor 2 fusions in Taiwan: from the evidence of the phase II trial and the perspective of Taiwan's National Health Insurance Administration.

Zi-Rong Chen, Chen-Han Chueh, Nai-Jung Chiang

Pageof 2

Frequent Collaborators

7 joint publications

Yi-Wen Tsai

3 joint publications

Yu-Wen Wen

3 joint publications

Nai-Jung Chiang

2 joint publications

Zi-Rong Chen

2 joint publications

Ming-Neng Shiu

2 joint publications

Wai-Hou Li

2 joint publications

I-Ting Wang

2 joint publications

Wei-Ming Huang

1 joint publications

Pei-Kuan Ho

1 joint publications

Ming-Yu Hong

Frequent Collaborators

7 joint publications

Yi-Wen Tsai

3 joint publications

Yu-Wen Wen

3 joint publications

Nai-Jung Chiang

2 joint publications

Zi-Rong Chen

Top Related Videos

Robotic Taj Mahal Hepatectomy for Hilar Cholangiocarcinoma

Robotic Taj Mahal Hepatectomy for Hilar Cholangiocarcinoma

Published on : Jul 14, 2022

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on : Feb 07, 2021

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on : Sep 27, 2024

See more related videos

Top Related Videos

Robotic Taj Mahal Hepatectomy for Hilar Cholangiocarcinoma

Robotic Taj Mahal Hepatectomy for Hilar Cholangiocarcinoma

Published on : Jul 14, 2022

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on : Feb 07, 2021

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on : Sep 27, 2024

See more related videos